Evaluation of resting brain conditions measured by two different methods (i.v. and oral administration) with ^<18> F-FDG-PET

• MASUD Mehedi

  Division of Nuclear Medicine, Cyclotron Radioisotope Center, Tohoku University

• YAMAGUCHI Keiichiro

  Division of Nuclear Medicine, Cyclotron Radioisotope Center, Tohoku University

• RIKIMARU Hisashi

  Division of Nuclear Medicine, Cyclotron Radioisotope Center, Tohoku University

• TASHIRO Manabu

  Division of Nuclear Medicine, Cyclotron Radioisotope Center, Tohoku University

• OZAKI Kaoru

  Division of Nuclear Medicine, Cyclotron Radioisotope Center, Tohoku University

• WATANUKI Shoichi

  Division of Nuclear Medicine, Cyclotron Radioisotope Center, Tohoku University

• MIYAKE Masayasu

  Division of Nuclear Pharmacology, Cyclotron Radioisotope Center, Tohoku University

• IDO Tatsuo

  Division of Nuclear Pharmacology, Cyclotron Radioisotope Center, Tohoku University

• ITOH Masatoshi

  Division of Nuclear Medicine, Cyclotron Radioisotope Center, Tohoku University

収録刊行物

• Annals of nuclear medicine

  Annals of nuclear medicine 15 (1), 69-73, 2001-02

キーワード

• 3D-PET
• FDG
• oral intake
• resting condition
• pooled control

詳細情報

• CRID: 1570572699705015168
• NII論文ID: 10008051259
• NII書誌ID: AA10708017
• ISSN: 09147187
• Web Site: https://search.jamas.or.jp/link/ui/2001182367
• 本文言語コード: en
• データソース種別:
  • CiNii Articles